Lipoprotein (a) [aapp, bacs]
Isoforms [aapp]
fibrinolytic [topp]
activity [dora]
Post-Menopause [orgf]
influential [idcn]
Hormone replacement therapy [topp]
Epidemiological Studies [resa]
Suggest [idcn]
Hormone replacement therapy [topp]
Decrease [qlco]
Cardiovascular disease [dsyn]
postmenopausal [tmco]
Women [popg]
Several [qnco]
Mechanisms [ftcn]
Including [ftcn]
Modification [ftcn]
fibrinolytic [topp]
System [ftcn]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Study [mnob]
influential [idcn]
Levels [qlco]
Isoforms [aapp]
Lp(a) [aapp, bacs]
fibrinolytic [topp]
activity [dora]
postmenopausal [tmco]
Women [popg]
Comparison [acty]
Pre-Menopause [phsf]
Hormone replacement therapy [topp]
Parameters [fndg]
Post-Menopause [orgf]
Plasma [bdsu]
Lp(a) [aapp, bacs]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Inverse [qlco]
Correlation [qlco]
Observed [ftcn]
Lp(a) [aapp, bacs]
Pai [idcn]
i levels [inpr]
Plasmin [aapp, enzy, phsu]
Generation [tmco]
Plasma sample [bdsu]
Low weight [fndg]
Molecular [qlco]
Apo-A [aapp, bacs]
Isoforms [aapp]
Plasmin [aapp, enzy, phsu]
Inhibition [menp]
Plasmas [bdsu]
High molecular weight [qlco]
Apo-A [aapp, bacs]
Isoforms [aapp]
Levels [qlco]
Lp(a) [aapp, bacs]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Hormone replacement therapy [topp]
Induced [ftcn]
Decrease [qlco]
Lp(a) [aapp, bacs]
Pai [idcn]
i levels [inpr]
Oestradiol level [lbpr]
fibrinolytic [topp]
activity [dora]
Correlation [qlco]
Percentage [qnco]
Variation [qlco]
Lp(a) [aapp, bacs]
Plasmin [aapp, enzy, phsu]
Generation [tmco]
Percentage [qnco]
Variation [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Euglobulin Lysis Time [lbpr]
Hormone replacement therapy [topp]
fibrinolytic [topp]
activity [dora]
Observed [ftcn]
Women [popg]
Hormone replacement therapy [topp]
Independent [idcn]
Mechanisms [ftcn]
Decrease [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Decrease [qlco]
Inhibition [menp]
Plasmin [aapp, enzy, phsu]
Generation [tmco]
Decrease [qlco]
Lp(a) [aapp, bacs]
